Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Channel Capital launches event driven high yield fund

Wednesday, October 23, 2013
Opalesque Industry Update - Channel Capital Advisors LLP announced the launch of its high yield catalyst fund which began trading at the beginning of this month. The fund seeks to generate 10% -12% net returns with low volatility and little correlation to the major markets.

The fund invests mainly in liquid bonds, equity and CDS. The strategy seeks to identify mispriced corporate debt where a catalyst will drive price realignment and profit realization.

The fund is managed by Peter Bakker, former high yield portfolio manager at Lazard and SGS, and Frits Lieuw-kie-song, former high yield portfolio manager at LKS and SGS. “We are both delighted to be back working together at an interesting time in the credit markets.” said Frits, “and we are both very excited to bring our strategy to Channel given their track record in corporate credit and the stability of the management platform.”

“We feel Frits and Peter have the talent, focus and discipline to maximise this investment opportunity.” said Walter Gontarek, Chief Executive of Channel. “Their pedigree is a complement to our own credit expertise and their return profile has little correlation to traditional credit market indices.”

The launch of this fund marks an important new initiative for Channel, which provides risk oversight, operational support and initial capital for the new strategy.

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its